We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byTravon Leming
Modified about 1 year ago
Roy Temes MD MBA, Joseph Lahorra MD, Inderjit Gill MD, Joseph Tomashefski Jr. MD, Thomas Rice MD
26 year old with progressing interstitial lung disease over 1.5 years Reformed IV drug user, HIV negative
Robotic wedge biopsy, discharged following day Pathology: Talc induced pulmonary granulomas (TIPG) Cultures (including AFB) negative
Cause: Injected tablet adulterants and fillers (talc, cellulose, fibers, other) Result: Loss of pulmonary vasculature, pulmonary hypertension, RVH Treatment (1): Medical: Steroids (inhaled budesonide), vasodilators (hydralazine) Treatment (2): Surgical: Lung transplantation Outcome: Pulmonary insufficiency and/or death
Include TIPG in differential diagnosis of interstitial disease in appropriate clinical setting Findings pathognomonic for drug abuse
Cho Ray Hospital Ho Chi Minh City, Vietnam December 20, 2013.
Hepatitis C Treatment in Corrections: New Medicine, New Challenges Spencer Epps, MD, MBA, Medical Director Delaware Department of Correction James Welch,
Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research.
ISCEE Respiratory System 23 rd Nov CASE PRESENTATION 1 Mrs R, 44 years old lady with no previous medical or surgical history Mrs R, 44 years old.
ALOK SINHA Department of Medicine Manipal College of Medical Sciences Pokhara, Nepal.
Hepatitis C Associated with Polyarteritis Nodosa Bindiya Magoon, MD ACP Associate member, Elias Ghandour, MD, Good Samaritan Hospital, Baltimore, Maryland.
Interesting Case Rounds Nicole Kirkpatrick February 7, 2008.
MGH Research in IPF: Identifying New Targets for Effective Drug Therapies Andrew M. Tager, M.D. Interstitial Lung Disease Program Pulmonary and Critical.
Dr. Essam El Moghazy NTP Egypt. The Global burden of TB in million deaths in 2008 – 98% of these in developing world 11–13% of incident cases.
By Eman I. Desoki MsC, Intensive Care Medicine. ICU Fellow Assistant in NHTMRI.
PROF.HANAN HABIB & PROF A.M.KAMBAL DEPRTMENT OF PATHOLOGY,MICROBIOLOGY UNIT KSU TUBERCULOSIS Respiratory Block.
Clinical Presentation and Diagnosis of Tuberculosis Your name Institution/organization Meeting Date International Standards 1-5.
PH: Who Ya Gonna Call Pulm Consults Lana Melendres Pulm/CC Division Pulm Htn Program Director 4/24/13.
Pericarditis, Endocarditis, Myocarditis Victor Politi, M.D., FACP Medical Director, SVCMC, School of Allied Health Professions, Physician Assistant Program.
Chronic Productive Cough Dr. Miao Shang Su. Present History - A 5-year-old girl come to your clinic for the first time. Her mother reports that the child.
New England TB Control Program HIV and TB Joseph Gadbaw, Jr., MD Lawrence and Memorial Hospital New London, CT.
TB: A Global Emergency 1/3 of the world (2 billion people) infected 1 person infected/second resulting in >30 million new infections, 8 million new cases.
OSHA Tuberculosis Training This module is for any associate who needs TB training OSHA Tuberculosis Training This module is for any associate who needs.
PH Pulmonary Hypertension. PH Pulmonary hypertension is an abnormal elevation of the pulmonary artery pressure (PAP) and the pulmonary vascular resistance.
Rash. ADULT ONSET MINIMAL CHANGE DISEASE Nephrology Grand Rounds Aditya Mattoo, MD October 20 th, 2009.
Treatment and Prevention of Opportunistic Infections: Options for the Caribbean Region Excerpted from presentation by Jonathan E. Kaplan, M.D.
KCMC Case Presentation: A 20 year-old male with Altered Mental Status Jesse Waggoner Resident, Internal Medicine International Health Elective.
Community Acquired Pneumonia in a Young Diabetic June 21, 2006 John N Landis, MD Chief, Pulmonary Medicine Baystate Medical Center Springfield, MA.
Aerobic.,AFB, NO Gram stain, 60% Lipid GT=8-24 hrs Human are natural reservior One third TB 30 Million active disease 3 Million die.
FUNGAL DISEASES IN THE RESPIRATORY, EXCRETORY & CIRCULATORY SYSTEMS By: Macatangay, Rachel C. BS BIO 3A.
David J. Hass, MD Assistant Clinical Professor of Medicine Yale University School of Medicine Gastroenterology Center of Connecticut, P.C.
Chapter 23 Q. _____ are drugs that are used to treat or prevent disease or other conditions. Chapter Review Choose the appropriate option. 1.Medicines.
© 2016 SlidePlayer.com Inc. All rights reserved.